Paper Details

  1. Home
  2. Paper Details

Profile of rifaximin and its potential in the treatment of irritable bowel syndrome.

Author: IorioNatalya, MalikZubair, ScheyRon

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Rifaximin is a non-absorbable antibiotic that targets the gastrointestinal tract and has been shown to improve symptoms of irritable bowel syndrome, such as bloating, flatulence, stool consistency, and abdominal pain. It has a side-effect profile similar to placebo.
Paper Details　
Original Abstract of the Article :
Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by recurrent abdominal pain and abnormal bowel patterns. Alteration in gut flora, visceral hypersensitivity, and abnormal bowel motility are among numerous factors in the complex pathophysiology of IBS. An...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467648/

データ提供：米国国立医学図書館（NLM）

Rifaximin: A Potential Solution for Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a common and often frustrating gastrointestinal disorder. This study examines the potential of rifaximin, a non-absorbable antibiotic, as a treatment option for IBS. The researchers explored the mechanisms of action of rifaximin and reviewed its efficacy in clinical trials. They found that rifaximin can effectively reduce symptoms associated with IBS, including abdominal pain, bloating, and flatulence. The study concluded that rifaximin is a safe and promising treatment option for IBS.

A Road to Relief for Irritable Bowel Syndrome

This research sheds light on the potential of rifaximin to provide relief for individuals suffering from IBS. The study highlights the drug's efficacy in reducing symptoms and its favorable safety profile. Imagine a camel seeking a cool oasis in a harsh desert. Rifaximin acts like a refreshing oasis, providing relief from the discomfort and disruptions caused by IBS.

Finding Balance in the Gut

This study reminds us that a healthy gut is essential for overall well-being. By targeting the gut microbiome, rifaximin offers a potential solution for managing IBS. It's a reminder that our gut health is intricately linked to our overall health and that addressing imbalances in the gut microbiome can have a positive impact on our overall health.

Dr. Camel's Conclusion

This study, like a camel seeking a cool oasis in a harsh desert, explores the potential of rifaximin to provide relief from the discomfort of IBS. By targeting the gut microbiome, rifaximin offers a potential solution for managing this challenging condition.

Date :
  1. Date Completed 2015-06-19
  2. Date Revised 2020-09-30
Further Info :

Pubmed ID

26089696

DOI: Digital Object Identifier

PMC4467648

Related Literature

Article Analysis
・Side Effects of rifaximin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.